vs
Arcutis Biotherapeutics, Inc.（ARQT）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
LiveRamp Holdings, Inc.的季度营收约是Arcutis Biotherapeutics, Inc.的1.6倍（$212.2M vs $129.5M），LiveRamp Holdings, Inc.净利率更高（18.8% vs 13.4%，领先5.4%），Arcutis Biotherapeutics, Inc.同比增速更快（81.5% vs 8.6%），过去两年Arcutis Biotherapeutics, Inc.的营收复合增速更高（61.6% vs 11.1%）
Arcutis Biotherapeutics是一家临床阶段生物制药企业，专注于开发和商业化免疫介导皮肤病领域的创新处方疗法，产品管线覆盖银屑病、特应性皮炎、斑秃等适应症，主要服务美国市场的患者及医疗服务提供者，填补皮肤科诊疗领域的未满足需求。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
ARQT vs RAMP — 直观对比
营收规模更大
RAMP
是对方的1.6倍
$129.5M
营收增速更快
ARQT
高出72.9%
8.6%
净利率更高
RAMP
高出5.4%
13.4%
两年增速更快
ARQT
近两年复合增速
11.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $129.5M | $212.2M |
| 净利润 | $17.4M | $39.9M |
| 毛利率 | 91.0% | 71.9% |
| 营业利润率 | 14.2% | 18.6% |
| 净利率 | 13.4% | 18.8% |
| 营收同比 | 81.5% | 8.6% |
| 净利润同比 | 261.2% | 255.7% |
| 每股收益（稀释后） | $0.14 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARQTRAMP
| Q4 25 | $129.5M | $212.2M | ||
| Q3 25 | $99.2M | $199.8M | ||
| Q2 25 | $81.5M | $194.8M | ||
| Q1 25 | $65.8M | $188.7M | ||
| Q4 24 | $71.4M | $195.4M | ||
| Q3 24 | $44.8M | $185.5M | ||
| Q2 24 | $30.9M | $176.0M | ||
| Q1 24 | $49.6M | $171.9M |
净利润ARQTRAMP
| Q4 25 | $17.4M | $39.9M | ||
| Q3 25 | $7.4M | $27.4M | ||
| Q2 25 | $-15.9M | $7.7M | ||
| Q1 25 | $-25.1M | $-6.3M | ||
| Q4 24 | $-10.8M | $11.2M | ||
| Q3 24 | $-41.5M | $1.7M | ||
| Q2 24 | $-52.3M | $-7.5M | ||
| Q1 24 | $-35.4M | $-5.4M |
毛利率ARQTRAMP
| Q4 25 | 91.0% | 71.9% | ||
| Q3 25 | 91.2% | 70.2% | ||
| Q2 25 | 90.8% | 70.1% | ||
| Q1 25 | 86.6% | 69.3% | ||
| Q4 24 | 90.3% | 71.9% | ||
| Q3 24 | 87.7% | 72.4% | ||
| Q2 24 | 88.8% | 70.6% | ||
| Q1 24 | 93.4% | 72.2% |
营业利润率ARQTRAMP
| Q4 25 | 14.2% | 18.6% | ||
| Q3 25 | 8.6% | 10.7% | ||
| Q2 25 | -17.9% | 3.7% | ||
| Q1 25 | -37.3% | -6.1% | ||
| Q4 24 | -10.7% | 7.5% | ||
| Q3 24 | -87.3% | 4.0% | ||
| Q2 24 | -162.3% | -3.0% | ||
| Q1 24 | -63.8% | -8.3% |
净利率ARQTRAMP
| Q4 25 | 13.4% | 18.8% | ||
| Q3 25 | 7.5% | 13.7% | ||
| Q2 25 | -19.5% | 4.0% | ||
| Q1 25 | -38.1% | -3.3% | ||
| Q4 24 | -15.1% | 5.7% | ||
| Q3 24 | -92.8% | 0.9% | ||
| Q2 24 | -169.6% | -4.3% | ||
| Q1 24 | -71.4% | -3.1% |
每股收益（稀释后）ARQTRAMP
| Q4 25 | $0.14 | $0.62 | ||
| Q3 25 | $0.06 | $0.42 | ||
| Q2 25 | $-0.13 | $0.12 | ||
| Q1 25 | $-0.20 | $-0.10 | ||
| Q4 24 | $-0.09 | $0.17 | ||
| Q3 24 | $-0.33 | $0.03 | ||
| Q2 24 | $-0.42 | $-0.11 | ||
| Q1 24 | $-0.32 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $42.9M | $403.4M |
| 总债务越低越好 | $109.0M | — |
| 股东权益账面价值 | $189.5M | $962.3M |
| 总资产 | $433.0M | $1.3B |
| 负债/权益比越低杠杆越低 | 0.58× | — |
8季度趋势，按日历期对齐
现金及短期投资ARQTRAMP
| Q4 25 | $42.9M | $403.4M | ||
| Q3 25 | $47.1M | $376.9M | ||
| Q2 25 | $72.7M | $371.1M | ||
| Q1 25 | $53.1M | $420.8M | ||
| Q4 24 | $71.3M | $384.3M | ||
| Q3 24 | $134.9M | $348.4M | ||
| Q2 24 | $84.3M | $342.7M | ||
| Q1 24 | $190.1M | $368.9M |
总债务ARQTRAMP
| Q4 25 | $109.0M | — | ||
| Q3 25 | $108.5M | — | ||
| Q2 25 | $108.0M | — | ||
| Q1 25 | $107.6M | — | ||
| Q4 24 | $107.2M | — | ||
| Q3 24 | $204.6M | — | ||
| Q2 24 | $203.8M | — | ||
| Q1 24 | $202.8M | — |
股东权益ARQTRAMP
| Q4 25 | $189.5M | $962.3M | ||
| Q3 25 | $158.1M | $943.8M | ||
| Q2 25 | $139.0M | $947.8M | ||
| Q1 25 | $142.7M | $948.9M | ||
| Q4 24 | $157.5M | $957.7M | ||
| Q3 24 | $156.6M | $932.1M | ||
| Q2 24 | $186.4M | $951.9M | ||
| Q1 24 | $224.9M | $949.1M |
总资产ARQTRAMP
| Q4 25 | $433.0M | $1.3B | ||
| Q3 25 | $371.0M | $1.2B | ||
| Q2 25 | $352.4M | $1.2B | ||
| Q1 25 | $344.1M | $1.3B | ||
| Q4 24 | $348.9M | $1.3B | ||
| Q3 24 | $437.4M | $1.2B | ||
| Q2 24 | $444.8M | $1.2B | ||
| Q1 24 | $478.5M | $1.2B |
负债/权益比ARQTRAMP
| Q4 25 | 0.58× | — | ||
| Q3 25 | 0.69× | — | ||
| Q2 25 | 0.78× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.68× | — | ||
| Q3 24 | 1.31× | — | ||
| Q2 24 | 1.09× | — | ||
| Q1 24 | 0.90× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $26.2M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | 0.1% |
| 现金转化率经营现金流/净利润 | 1.51× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ARQTRAMP
| Q4 25 | $26.2M | — | ||
| Q3 25 | $-1.8M | $57.4M | ||
| Q2 25 | $324.0K | $-15.8M | ||
| Q1 25 | $-30.4M | — | ||
| Q4 24 | $-748.0K | $45.1M | ||
| Q3 24 | $-34.7M | $55.6M | ||
| Q2 24 | $-45.1M | $-9.3M | ||
| Q1 24 | $-31.6M | — |
自由现金流ARQTRAMP
| Q4 25 | — | — | ||
| Q3 25 | — | $56.8M | ||
| Q2 25 | $246.0K | $-16.2M | ||
| Q1 25 | $-31.0M | — | ||
| Q4 24 | — | $44.8M | ||
| Q3 24 | $-34.8M | $55.4M | ||
| Q2 24 | — | $-9.6M | ||
| Q1 24 | — | — |
自由现金流率ARQTRAMP
| Q4 25 | — | — | ||
| Q3 25 | — | 28.4% | ||
| Q2 25 | 0.3% | -8.3% | ||
| Q1 25 | -47.1% | — | ||
| Q4 24 | — | 22.9% | ||
| Q3 24 | -77.8% | 29.8% | ||
| Q2 24 | — | -5.4% | ||
| Q1 24 | — | — |
资本支出强度ARQTRAMP
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | 0.1% | 0.2% | ||
| Q1 25 | 0.9% | 0.2% | ||
| Q4 24 | 0.0% | 0.1% | ||
| Q3 24 | 0.3% | 0.1% | ||
| Q2 24 | 0.0% | 0.1% | ||
| Q1 24 | 0.0% | 1.0% |
现金转化率ARQTRAMP
| Q4 25 | 1.51× | — | ||
| Q3 25 | -0.24× | 2.09× | ||
| Q2 25 | — | -2.04× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.02× | ||
| Q3 24 | — | 32.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
